Literature DB >> 17065357

Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene.

Nathalie Vionnet1, David Tregouët, Gbenga Kazeem, Ivo Gut, Per-Henrik Groop, Lise Tarnow, Hans-Henrik Parving, Samy Hadjadj, Carol Forsblom, Martin Farrall, Dominique Gauguier, Roger Cox, Fumihiko Matsuda, Simon Heath, Alexandre Thévard, Rachel Rousseau, François Cambien, Michel Marre, Mark Lathrop.   

Abstract

Linkage studies have mapped loci for diabetic nephropathy and associated phenotypes on chromosome 3q. We studied 14 plausible candidate genes in the linkage region because of their potential role in vascular complications. In a large-scale study of patients from Denmark, Finland, and France who have type 1 diabetes, 1,057 case and 1,127 control subjects, as well as 532 trios, were investigated for association with diabetic nephropathy. We analyzed 69 haplotype-tagging single nucleotide polymorphisms and nonsynonymous variants that were identified by sequencing. Polymorphisms in three genes, glucose transporter 2 (SLC2A2), kininogen (KNG1), and adiponectin (ADIPOQ), showed nominal association with diabetic nephropathy in single-point analysis. The T-allele of SLC2A2_16459CT was associated with a decreased risk of diabetic nephropathy (odds ratio 0.79 [95% CI 0.66-0.96], P = 0.016), whereas the T-allele of KNG_7965CT and the A-allele of ADIPOQ_prom2GA were associated with increased risk of nephropathy (1.17 [1.03-1.32], P = 0.016; 1.46 [1.11-1.93], P = 0.006, respectively). Analyses of the transmission disequilibrium test showed similar trends only for ADIPOQ_prom2GA with the overtransmission of the A-allele to patients with diabetic nephropathy (1.52 [0.86-2.66], P = NS) and of the G-allele to patients without diabetic nephropathy (0.50 [0.27-0.92], P = 0.026). The overall significance for this variant (nominal P = 0.011) suggests that ADIPOQ might be involved in the development of diabetic nephropathy.

Entities:  

Mesh:

Year:  2006        PMID: 17065357     DOI: 10.2337/db06-0271

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

1.  Renal complications of childhood type 1 diabetes.

Authors:  Jean-Claude Carel; Claire Levy-Marchal
Journal:  BMJ       Date:  2008-03-18

2.  Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus.

Authors:  Bing He; Anne-May Osterholm; Anna Hoverfält; Carol Forsblom; Eyrún Edda Hjörleifsdóttir; Ann-Sofie Nilsson; Maikki Parkkonen; Janne Pitkäniemi; Astrádur Hreidarsson; Cinzia Sarti; Amy Jayne McKnight; A Peter Maxwell; Jaakko Tuomilehto; Per-Henrik Groop; Karl Tryggvason
Journal:  Am J Hum Genet       Date:  2008-12-11       Impact factor: 11.025

Review 3.  Insights into the genetic architecture of diabetic nephropathy.

Authors:  Nicholette D Palmer; Barry I Freedman
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

4.  Relationship between ADIPOQ gene, circulating high molecular weight adiponectin and albuminuria in individuals with normal kidney function: evidence from a family-based study.

Authors:  C Menzaghi; S De Cosmo; M Copetti; L Salvemini; C De Bonis; D Mangiacotti; G Fini; F Pellegrini; V Trischitta
Journal:  Diabetologia       Date:  2011-01-13       Impact factor: 10.122

5.  The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.

Authors:  A Möllsten; A Jorsal; M Lajer; N Vionnet; L Tarnow
Journal:  Diabetologia       Date:  2009-10-16       Impact factor: 10.122

6.  Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms.

Authors:  Harvest F Gu
Journal:  Biomark Insights       Date:  2009-10-13

7.  Decorin deficiency enhances progressive nephropathy in diabetic mice.

Authors:  Kevin Jon Williams; Gang Qiu; Hitomi Katoaka Usui; Stephen R Dunn; Peter McCue; Erwin Bottinger; Renato V Iozzo; Kumar Sharma
Journal:  Am J Pathol       Date:  2007-09-20       Impact factor: 4.307

8.  Adiponectin regulates albuminuria and podocyte function in mice.

Authors:  Kumar Sharma; Satish Ramachandrarao; Gang Qiu; Hitomi Kataoka Usui; Yanqing Zhu; Stephen R Dunn; Raogo Ouedraogo; Kelly Hough; Peter McCue; Lawrence Chan; Bonita Falkner; Barry J Goldstein
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 9.  Genetics of diabetes complications.

Authors:  Sami Alkayyali; Valeriya Lyssenko
Journal:  Mamm Genome       Date:  2014-08-29       Impact factor: 2.957

10.  Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus.

Authors:  Yaomin Hu; Pamela J Kaisaki; Karène Argoud; Steven P Wilder; Karin J Wallace; Peng Y Woon; Christine Blancher; Lise Tarnow; Per-Henrik Groop; Samy Hadjadj; Michel Marre; Hans-Henrik Parving; Martin Farrall; Roger D Cox; Mark Lathrop; Nathalie Vionnet; Marie-Thérèse Bihoreau; Dominique Gauguier
Journal:  BMC Med Genomics       Date:  2009-07-09       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.